Lacrimal gland, tear film, and dry eye syndromes 3: basic science and clinical relevance
Gespeichert in:
| Format: | Tagungsbericht Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York
Kluwer Academic/Plenum Publishers
2002
|
| Schriftenreihe: | Advances in experimental medicine and biology
v. 506 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | "Proceedings of the 3rd International Conference on the Lacrimal Gland, Tear Film, and Dry Eye Syndromes: Basic Science and Clinical Relevance, November 15-18, 2000, Maui, Hawaii"--T.p. verso. - Includes bibliographical references and index. |
| Beschreibung: | XXVI, 1385 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV014542210 | ||
| 003 | DE-604 | ||
| 005 | 20030701 | ||
| 007 | t | ||
| 008 | 020626s2002 xxuad|| |||| 10||| eng d | ||
| 010 | |a 2002072992 | ||
| 035 | |a (OCoLC)50035786 | ||
| 035 | |a (DE-599)BVBBV014542210 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-91 | ||
| 050 | 0 | |a QP188.T4 | |
| 050 | 0 | |a RE216.D78 | |
| 082 | 0 | |a 617.7/64 |2 21 | |
| 084 | |a YO 7105 |0 (DE-625)153952:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Lacrimal gland, tear film, and dry eye syndromes 3 |b basic science and clinical relevance |c edited by David A. Sullivan ... [et al.] |
| 246 | 1 | 3 | |a Lacrimal gland, tear film, and dry eye syndromes three |
| 264 | 1 | |a New York |b Kluwer Academic/Plenum Publishers |c 2002 | |
| 300 | |a XXVI, 1385 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Advances in experimental medicine and biology |v v. 506 | |
| 500 | |a "Proceedings of the 3rd International Conference on the Lacrimal Gland, Tear Film, and Dry Eye Syndromes: Basic Science and Clinical Relevance, November 15-18, 2000, Maui, Hawaii"--T.p. verso. - Includes bibliographical references and index. | ||
| 650 | 4 | |a Appareil lacrymal - Congrès | |
| 650 | 4 | |a Larmes - Congrès | |
| 650 | 4 | |a Syndromes de l'il sec - Congrès | |
| 650 | 4 | |a Dry Eye Syndromes |v Congresses | |
| 650 | 4 | |a Dry eye syndromes |v Congresses | |
| 650 | 4 | |a Lacrimal Apparatus |v Congresses | |
| 650 | 4 | |a Lacrimal apparatus |v Congresses | |
| 650 | 4 | |a Tears |v Congresses | |
| 650 | 4 | |a Tears |x physiology |v Congresses | |
| 650 | 0 | 7 | |a Physiologie |0 (DE-588)4045981-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Keratokonjunktivitis sicca |0 (DE-588)4270782-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Tränenapparat |0 (DE-588)4117240-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Tränenflüssigkeit |0 (DE-588)4185825-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Tränendrüse |0 (DE-588)4185823-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 2000 |z Maui |2 gnd-content | |
| 689 | 0 | 0 | |a Tränendrüse |0 (DE-588)4185823-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Tränenflüssigkeit |0 (DE-588)4185825-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Keratokonjunktivitis sicca |0 (DE-588)4270782-1 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Tränenapparat |0 (DE-588)4117240-1 |D s |
| 689 | 3 | 1 | |a Physiologie |0 (DE-588)4045981-0 |D s |
| 689 | 3 | |5 DE-604 | |
| 700 | 1 | |a Sullivan, David A. |e Sonstige |4 oth | |
| 711 | 2 | |a International Conference on the Lacrimal Gland, Tear Film and Dry Eye Syndromes |n 3 |d 2000 |j Sonstige |0 (DE-588)1244280-X |4 oth | |
| 856 | 4 | 2 | |m Digitalisierung TU Muenchen |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009891364&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-009891364 | ||
Datensatz im Suchindex
| _version_ | 1804129325516062720 |
|---|---|
| adam_text | Contents
Claes
H. Dohiman
Conference Address
1.
Understanding Dry Eye Syndrome
...........................................................................................................3
K.Tsubota
Lacrimal
Gland: Cellular and Molecular Biology
2
GDNF Family Signaling in
Exocrine
Tissues: Distinct Roles for GDNF and Neurturin in
Parasympathetic Neuron Development
.....................................................................................19
J. Rossi and M.S. Airaksinen
3.
The Influence of Aging in the Insulin Signaling System in Rat
Exocrine
Glands
................................27
E.M.
Rocha,
C.R.O.
Carvalho,
M.J.A. Saad, and L.A.
Velloso
4.
Cloning, Partial Sequencing and Expression of Rabbit
Lacrimal
Gland Hexosaminidase
...................33
J.P. Gierow, E.C.
Sjögren, C. Magnusson
and
S.Tågerud
5.
Differential Expression of Adenylyl Cyclase mRNAs in
Lacrimal
Glands of NZB/NZW and
NOD Pre-Autoimmune Mice
.....................................................................................................41
M.A. Meneray and
Т.Е.
Lallier
6.
M3 Receptor Autoimmunity.- Losing Tolerance to a Familiar Protein
..................................................51
A. K. Mircheff, L.Qian, J. Xie, Y. Wang, and S.F. Hamm-Alvarez
7.
Presence of a- and
ß-Integrin
Subunits in Rabbit
Lacrimal
Gland Acinar Cells Cultured on a
Laminin-Rich Matrix
.................................................................................................................59
J.P. Gierow, S.
Andersson,
and E.C.
Sjögren
8.
The Effects of Sensory and Parasympathetic Denervation on the Kinases and Initiation Factors
Controlling Protein Synthesis in the
Lacrimal
Gland
...............................................................65
D.H.
Nguyen, R.W.
Beuerman,
and H. Toshida
9.
Familial Dysautonomia in Review: Diagnosis and Treatment of Ocular Manifestations
.....................71
C.A. Josaitis and M. Matisoff
10.
Somatostatin-Like Immunoreactivity (SLIR) in Rat Harderian and Meibomian Glands and
Glands of
Zeis
............................................................................................................................81
M. Lorber
11. Neuronal
Nitric
Oxide Synthase
is Expressed in the Mouse
Lacrimal
Gland and in Neurons of
Pterygopalatine Ganglion
..........................................................................................................91
С
Ding, B. Waicott, and K.T. Keyser
12.
Effects of Ageing on Secretagogue-Evoked Protein Output and Peroxidase Secretion and
Protein Synthesis in the Isolated Rat
Lacrimal
Gland
..............................................................97
3.
Singh, C.E. Draper, and E. Adeghate
13.
Effects of Ageing on Changes in Morphology of the Rat
Lacrimal
Gland
.........................................103
E. Adeghate, C.E. Draper, and J. Singh
14.
The Role of Gap Junctions in
Lacrimal Acinar
Cells: The Formation of Tears
.................................109
P.R. Brink, V.Valiunas, L. Moore, A. Birzgalis, and B. Waicott
15.
Lipase
mRNAs Expressed in
Lacrimal
and Harderian Glands
............................................................115
S.G. Remington and J.D. Nelson
16.
Gender-Related Differences in Gene Expression of the
Lacrimal
Gland
............................................121
S.M. Richards, M. Liu,
B.D.
Sullivan, and DA. Sullivan
17.
Identification of Androgen-Regulated Genes in the
Lacrimal
Gland
..................................................129
M. Liu, S.M. Richards, F. Schirra, H. Yamagami,
B.D.
Sullivan, and D.A. Sullivan
18.
Identification of
Androgen
Receptors in Rabbit
Lacrimal
Gland by Immunohistochemistry
...........137
M.D. Aupperlee, J.T. Wertz K.E. Ingersoll, and J.L. Ubels
19.
Androgen
Influence of Lymphocyte Gene Expression
........................................................................143
W.R. Bijlsma, B.A.R.
Tonino,
S.M. Richards, M. Liu,
B.D.
Sullivan, and D.A. Sullivan
20.
Potential Role of Disrupted
Lacrimal
Acinar Cells in Dry Eye During Pregnancy
............................153
J. Schechter,
M.
Pidgeon,
D.
Chang, Y-C. Fong, M. Trousdale, and
N.
Chang
21.
A New Model System for Studying
Lacrimal
Physiology Using Cultured
Lacrimal
Gland
Acinar Cells on
Matrigel
Rafts
................................................................................................159
D.
Stevenson, J.E.
Schechter, T. Nakamuro, D. Chang, N.Y. Chang, M. Pidgeon,
H.
Zeng, A.K.
Mircheff, and M. Trousdale
Lacrimal
Gland and Ocular Surface: Signal Transduction,
Membrane Traffic and Fluid and Protein Secretion
22.
Genetic Separation of the Human Lacritin Gene ( LACRT ) and Triple A (Allgrove)
Syndrome on I2Q13
................................................................................................................167
R. Kumar, A. Huebner, and G.W. Laurie
23.
Ca2 Signaling in Polarized
Exocrine
Cells
...........................................................................................175
K. Kiselyov,
D.M.
Shin, X. Luo, S. B.H.
Ko,
and S. Muallem
24.
Role of Ca2 1 and Protein Kinase
С
in Cholinergic and ai-Adrenergic Agonists and EGF
Stimulated Mitogen-Activated Protein Kinase Activity in
Lacrimal
Gland
..........................185
J.D.
Rios, D.
Ferdman, V. Tepavcevic, R. Hodges, D. Zoukhri, and D.A. Dartt
25.
A Model of Fluid Secretion by the Acinar Cells of the Mouse
Lacrimal
Gland
.................................191
B. Waicott, L. Moore, A. Birzgalis,
N.
Claros,
and P.R. Brink
26.
Cytoskeletal Participation
in Stimulated Secretion and Compensatory Apical Plasma
Membrane Retrieval in
Lacrimal
Gland Acinar Cells
............................................................199
S.R. da Costa, S.
Andersson,
F.A. Yarber,
С
Okamoto, and S.F. Hamm-Alvarez
27.
Glycolipid-Rich Membrane
Microdomains
in
Lacrimal
Acinar Cell
Endomembrane Compartments
...............................................................................................207
L. Qian, J. Xie, and A.K. Mircheff
28.
Epidermal Growth Factor Traffic in
Lacrimal
Acinar Cells
................................................................213
J. Xie, L. Qian, S.F. Hamm-Alvarez, and A.K. Mircheff
29.
Immunocalization and Physiological Effect of Serotonin in the Porcine
Lacrimal
Gland
.................219
E. Adeghate, B. Zumbrunn, and J. Singh
30.
Effects of Preganglionic, Parasympathetic Denervation on the Rabbit
Lacrimation
..............................................................................................................................225
H. Toshida and R.W.
Beuerman
31
Prolactin Inhibits Carbachol-Dependent Secretion by
Lacrimal
Acinar Cells in Vitro
......................231
A.J. Casbon,
D.W.
Warren, and A.K. Mircheff
32.
Effect of Overexpression of Protein Kinase Cot on Rat
Lacrimal
Gland Protein Secretion
...............237
R.R. Hodges, A. Kazlauskas, A. Toker, and D.A. Dartt
33.
Epidermal Growth Factor Stimulates Fluid Transport in SV40 Transformed Rabbit
Lacrimal
Gland Cells
..............................................................................................................
243
P. Iserovich, M. Yiming, Z. Wang, V. Bildin,
P.S.
Reinach, and J.
Fischbarg
34.
Nucleoside and Nucleoride Stimulation of Fluid Secretion in the
Pigmented
Rabbit
Conjunctiva
..............................................................................................................................249
V.H.L.
Lee, A. Kulkami,
and M.H.I. Shiue
35.
Metabolism and Transport of Purinergic Receptor Agonists in Rabbit Conjunctival Epithelial
Cells
..........................................................................................................................................
255
H.J. Gukasyan, B.R. Yerxa, W.
Pendergast,
and V.H.L. Lee
36.
Potency and Duration of Action of Synthetic P2Y2 Receptor Agonists on Schirmer
Scores in Rabbits
......................................................................................................................
261
B.R. Yerxa, J.G. Douglass, P.P. Elena, T. Caillaud, T.
Amar, CRedick,
and W.M. Peterson
Mucins: Origin, Properties, Regulation and Function
37.
Mechanism by Which Bacterial Flagellin Stimulates Host
Mucin
Production
...................................269
N.
McNamara and
С
Basbaum
38.
Mucins and Ocular Surface Disease
.....................................................................................................
27^
S.H. Hibino and H.Watanabe
39.
Functional Processing of Ocular Mucins
..............................................................................................
2
M. Berry, A.P. Corfield, A. Harris, and D. Khan-Lim
40.
ERBB2 and Its Ligand MUC4 (Sialomucin Complex) in Rat
Lacrimal
Gland
..................................289
K.L. Carraway, M.E.
Carvajal,
P. Li, and C.A.C. Carraway
41.
Kole
of
Mitogen-Activated Protein Kinase
in Cholinergic Stimulation of Conjunctiva!
Goblet Cell Secretion
...............................................................................................................297
D.A. Dartt, H. Kanno, J.
Rios,
and D. Zoukhri
4?.
Isolation and Characterization of Human Goblet Cells in Vitro: Regulation of Proliferation
and Activation of Mitogen-Activated Protein Kinase by EGF and Carbachol
......................301
MA. Shatos, H. Kanno, P. Rubin, G.
Garza,
and D.A. Dartt
4 *
Human Conjunctival Epithelium in Culture: A Tool to Assay New Therapeutic Strategies
for Dry Eye
...............................................................................................................................307
Y. Diebold, M. Calonge, R.M. Corrales, M.V. Saez, S.Callejo, M.C.
Lázaro,
and J.M.
Herreras
44
Ocular Tff-Peptides: New Mucus-Associated Secretory Products of Conjunctival Goblet
Cells
..........................................................................................................................................313
G.
Langer,
W. Jagła, W.
Behrens-Baumann,
S.Walter, and
W.
Hoffmann
45.
Topically Applied
15-(S)-HETE
Stimulates
Mucin
Production by
Corneal
Epithelium
...................317
J.L. Ubels, M. Aupperlee, R.S. Jackson II, S.J.Van Dyken, and M. McCartney
46.
Effects of 15(S)-HETE on Human Conjunctival
Mucin
Secretion
......................................................323
J. Jumblatt, L. Cunningham, and M. Jumblatt
47.
Evaluation of the Effects of
1
5(S)-HETE on the
Corneal
Epithelial Cells:
An Electrophysiological and Cytochemical Study
.................................................................329
R.G.
Azar
and H.F. Edelhauser
48.
Preservation of
Corneal
Integrity by the
Mucin
SecretagoguelSÍSJ-HETE
in a Rabbit Model
of Desiccation-Induced Dry Eye
............................................................................................335
D.A. Gamache, Z.Y. Wei, L. Weimer, J.M. Spellman, and J.M. Yanni
49.
Purification and Chemical Characterization of the High Molecular Weight of
Glycoconjugate Fraction of the Bovine Tear Film and Comparison to Mucins
from Other Sources
..................................................................................................................341
M.S. Bail, K.N. Hollis-Watts,
N.
Karlsson,
N.
Packer, and M.D.P. Willcox
50.
Sialic Acid in Normal and Dry Eye Tear Fluid
....................................................................................347
Y. Nakamura,
N.
Yokoi, H. Tokushige, and S. Kinoshita
51.
Gefarnate Stimulates Goblet Cell
Repopulation
Following an Experimental Wound to
the Tarsal Conjunctiva in The Dry Eye Rabbit
.......................................................................353
H. Toshida, K.
Nakata,
T.
Hamáno,
M. Nakamura,
D.
Nguyen, and R.W.
Beuerman
52.
Mucin
Ophthalmic Solution Treatment of Dry Eye
.............................................................................359
T. Shigemitsu, Y. Shimizu, and K. Ishiguro
53.
The Lacuna
Sulci:
A New Test to Measure the Shrinkage of Ocular Surface, and Its
Relation with the Number of Goblet Cells
..............................................................................363
J. Murabe, L. ChenZhuo, E. Murabe, and
L. Rivas
Meibomian Gland and Tear Film Lipids: Structure,
Function and Control
54.
Meibomian Gland and Tear Film Lipids: Structure, Function and Control
........................................373
J. P. McCulley and W. Shine
55.
Androgen
Regulation
of Lipogenesis
...................................................................................................379
J.
V. Swinnen,
H.
Heemers,
W.
Heyns, and
G.
Verhoeven
56.
Sex steroids, the Meibomian Gland and Evaporative Dry Eye
............................................................389
D.A. Sullivan, H. Yamagami, M. Liu, R.J. Steagall, F. Schirra, T. Suzuki, K.L. Krenzer,
J.M. Cermak, R.M. Sullivan, S.M. Richards, D.A.
Schaumberg, M.R.
Dana,
and
B.D.
Sullivan
57.
The
Lipid
Layer and Stability of Tears in Human Newboms
..............................................................401
S. J.
Isenberg,
M.
Del
Signore,
A. Chen, and
J.
Wei
58.
Interface Properties of Simplified Tear-Like Fluids in Relation to
Lipid
and Aqueous Layers
Composition
.............................................................................................................................405
F.
Miano,
M.
Mazzone,
A. Giannetta,
V.
Enea,
P.
Mc
Cauley, A.Bailey,
and P.
С
Winlove
59.
Effect of an Oil and Water Emulsion on Tear Evaporation Rate
.........................................................419
E.I. Pearce, A. Tomlinson,
K.J.
Blades, H.K.
Falkenberg,
В.
Lindsay, and
CG.
Wilson
60.
Evaporation from the Human Tear Film Studied by
Interferometry
...................................................425
P.E.
King-Smith, B.A. Fink, and R.M. Hill
61.
The Effects of Dietary and Pharmacological Manipulation on
Lipid
Production in the
Meibomian and Harderian Glands of the Rabbit
....................................................................431
T.J. Millar and M.L. Pearson
62.
Correlations between Nutrient Intake and the Polar
Lipid
Profiles of
Meibomian Gland Secretions in Women with
Sjögren s
Syndrome
.....................................441
B.D.
Sullivan, J.M. Cermak, R.M. Sullivan, A.S. Papas, J.E. Evans, M.R. Dana,
and D.A. Sullivan
63.
Impact of
Androgen
Deficiency on the
Lipid
Profiles in Human Meibomian
Gland Secretions
......................................................................................................................
^9
B.D.
Sullivan, J.E. Evans, M.R. Dana, and D.A. Sullivan
64.
Gender-Associated Differences in Gene Expression of the Meibomian Gland
..................................459
H. Yamagami, S.M. Richards,
B.D.
Sullivan, M. Liu, R.J. Steagall, and D.A. Sullivan
65.
Androgen
Control of Gene Expression in the Rabbit Meibomian Gland
..........................................465
R.J. Steagall, H. Yamagami, L.A. Wickham, and D.A. Sullivan
66.
Androgen
Influence on Gene Expression in the Meibomian Gland
....................................................
H. Yamagami, F. Schirra, M. Liu, S.M. Richards,
B.D.
Sullivan, and D.A. Sullivan
67.
Estrogen and Progesterone Effects on the Morphology of the Mouse Meibomian Gland
.................483
T. Suzuki,
B.D.
Sullivan, M. Liu, F. Schirra, S.M. Richards, H. Yamagami,
and D.A. Sullivan
68.
Gene Expression and Fat Deposit in Primary Cultured Rat Meibomian Gland Cells
........................489
M.
Sumida,
M.
Kutsuna,
T. Kodarna,
and
Y. Ohashi
69-
The Effects of
Anionie
and Zwitterionic Phospholipids on the Tear Film
Lipid
Layer
....................495
DR.
Korb,
J.V. Greiner, andT. Glonek
70.
Alleviation of Computer-Induced Eye Discomfort Syndrome and Associated
Lipid
Layer
Changes
....................................................................................................................................
501
D.R.
Korb
xvii
71.
Effects of Fluorescein Instillation Methods on the Tear Film
Lipid
Layer
.........................................507
J.V. Greiner,
V.M.
Finnemore, J.M. Exford, J.P. Herman, T. Glonek, E.A.
Bueno,
and D.R.
Korb
72.
Blinking Frequency and the Thickness of the
Lipid
Layer
..................................................................513
A. Berke
73.
Assessment of Meibomian Gland Function by a Newly-Developed Laser Meibometer
...................517
A. Komuro, N.Yokoi, S.Kinoshita, J.M. Tiffany, A.J.
Bron,
and T. Suzuki
Ocular Surface Homeostasis I:
Tear Film Proteins and Stability
74.
The Tear Film and Defense Against Infection
.....................................................................................523
S.M.J. Fleiszig,
N.
McNamara, and D.J. Evans
75.
Nerve Growth Factor (NGF): An Important Molecule for Trophism and Healing of the
Ocular Surface
..........................................................................................................................531
S.
Bonini,
L.
Aloe,
S.
Bonini,
P.
Rama, A. Lamagna, and A.
Lambíase
76.
Changes in the Diurnal Pattern of the Distribution of
Gelatinases
and Associated Proteins in
Normal and Pathological Tear Fluids: Evidence That the PMN Cell is a Major Source
of MMP Activity in Tear Fluid
................................................................................................539
R.A. Sack, S. Same, A. Beaton,
B. Bogart,
and G. Lew
77.
Protection of Human Efferent Tear Ducts by Antimicrobial Peptides
................................................547
F.P. Paulsen, T. Pufe, U. Schaudig, J. Held-Feindt, J.
Lehmann, A.B.
Thaïe,
and
B.N.
Tillmann
78.
Tear Lipocalin: Structure, Function and Molecular Mechanisms of Action
.......................................555
B.J. Glasgow, A.R. Abduragimov, O.K. Gassymov, and T.N. Yusifov
79.
Vitamin
E
Associated with the Lipocalin Fraction of Human Tears
...................................................567
B.J. Glasgow, A.R. Abduragimov, O.K. Gassymov, T.N. Yusifov, E.C. Ruth,
and K.F. Faull
80.
Characterization of a Lipophilin in Rabbit Tears
.................................................................................573
B.J. Glasgow, A.R. Abduragimov, O.K. Gassymov, K.F. Faull, T.N. Yusifov,
and R.I.
Lehrer
81.
The Role of Lipocalin in Determining the Physical Properties of Tears
.............................................581
J.M. Tiffany and
B. Nagyova
82.
Age-Related Changes in Human Tear Composition and Stability
......................................................587
J.M. Tiffany and S.M.
Gouveia
83.
Dynamic Surface Activity of Biological Fluids, Ophthalmic Solutions
............................................599
S. Tonge, V. Rebeix, R.Young, and B.J.
Tigne
84.
Mass Spectrometric Techniques Applied to the Analysis of Human Tears: A Focus on
the
Peptide
and Protein Constituents
.......................................................................................601
K. Fung, C. Morris, and M.Duncan
xviii
85.
Insulin, Insulin Receptor
and Insulin-Like Growth
Factor-I
Receptor
on the Human
Ocular Surface
..........................................................................................................................607
E.M.
Rocha, D.A.
Cunha, E.M. Carneiro,
A.C.
Buschero, M.J.A. Saad,
and L.A. Velloso
86.
Immunodacryochemistry (Immunoferning): A New Screening
Method for Proteins in Tears
..........611
G.
van Setten
87.
Different
Concentration
of
Amino
Acids in Tears of Normal and Human Dry Eyes
.........................617
L. ChenZhou, J. Murube, A. Latorre, and R.M. Del Rio
88.
Changes in the Tear Protein Patterns of Diabetic Patients Using Two-Dimensional
Electrophoresis
.........................................................................................................................623
S.
Herber, F.H. Grus,
P. Sabuncuo, and A.J.
Augustin
Ocular Surface Homeostasis II: Tear Film, Cornea and
Conjunctiva Interactions
89.
Enzymatic Mechanisms in
Corneal
Ulcération
with Specific Reference to Familial
Dysautonomia: Potential for Genetic Approaches
..................................................................629
M.E.
Fini
and
S.A.
Slaugenhaupt
90.
Pathological Keratinization of Ocular Surface Epithelium
..................................................................641
S. Kinoshita, T. Nakamura, and K. Nishida
91.
Experimentally Induced Dry Eye Produces Ocular Surface
Inflammation
and Epithelial
Disease
.....................................................................................................................................647
D. Dursun, M. Wang, D. Monroy, D.-Q. Li, B.L. Lokeshwar, M.E. Stern,
and S.C.
Pflugfelder
92.
In Vivo Confocal Microscopy for Studying
Corneal
Diseases and Conditions Associated with
Corneal
Nerve Damage
............................................................................................................
T. Tervo, J.A.O. Moilanen, M.E. Rosenberg, I.S.J
Tuominen, T.
Valle,
and M.H. Vesaluoma
93.
Ocular Surface Changes in Type
1
Diabetic Patients
...........................................................................
^7
P. Aragona, S. Giuffnda, G.
Di Stefano,
F.
Ferreri,
A. Di Benedetto,
C. Bucolo,
and M.
Ciò
94.
Serum- and Serum Deprivation-Induced Transcriptional Profiles of Cultured Conjunctival
Epithelial Cells
........................................................................................................................
A. Higuchi, S. Shimmura, M.Ishii,
H
Aburatani, and K. Tsubota
95.
Shear-Induced ATP Release by Cultured Rabbit
Corneal
Epithelial Cells
.........................................677
S.P. Srinivas, R. Mutharasan, and S.M.J. Fleiszig
96.
The Role of Nitric Oxide in Ocular Surface Diseases
..........................................................................
J.C. Kim, T.B. Cheong, G.S. Park, M.H. Park, N.S. Kwon, and H.Y. Yoon
9?.
Relationship between in Vitro
Toxicity
of Benzakonium Chloride
(ВАС)
and ^
Preservative-Induced Dry Eye
................................................................;................................
M. De
Saint Jean,
С
Debbasch, F. Brignole,
Ш.
Warnet,
and
С
Baudouin
98.
Corneal
Epithelial Permeability and Dry Eye Treatment
.......................................................................
J.M. Benitez-Del-Castillo, C. Aranguez, and J. Garcia-Sanchez
six
99.
Observation
of Tear Film in Recurrent
Corneal
Erosion and Epithelial Basement Membrane
Dystrophy
.................................................................................................................................
707
J. Sugita,
N.
Yokoi, and S. Kinoshita
100.
The Effect of Tear Film and Ocular Surface Management on Myopic Lasik Outcomes
....................711
J.M.
Albietz, L.M
Lenton, and S.M. McLennan
101.
A Comparison of
Corneal
and Conjunctival Sensitivity to a Thermally Cooling Stimulus
...............719
P.J. Murphy, E. Armstrong, and L.A. Woods
102.
The Effect of Acupuncture on the Temperature of the Ocular Surface in Conjunctivitis Sicca
Measured by Non-Contact Thermography: Preliminary Results
...........................................723
J. Nepp, K. Tsubota, E. Goto, J. Schauersberger, G.
Schild,
К.
Jandrasits,
С.
Abela
and A. Wedrich
Immunity and Inflammation I: Influence of Cytokines,
Chemokines, Adhesion Molecules and Other
Immunoactive Agents
103.
Role of Immunity and Inflammation in
Corneal
and Ocular Surface Disease Associated with
Dry Eye
.....................................................................................................................................729
M.R. Dana and P. Hamrah
104.
Dry Eye and Delayed Tear Clearance: A Call To Arms
...................................................................739
S.C. PflugfeWer, A. Solomon, D. Dursun, and D.Q. Li
105.
Innate Immunity in the Cornea: A Putative Role for Keratocytes in the Chemokine Response to
Viral Infection of The Human Cornea
Stroma
........................................................................745
К.
Natarajan, J. Chodosh, and R.C. Kennedy
106.
The Role of ICAM-1 as a Signal Protein for Predisposition of Ocular Surface Inflammation
..........753
M.E. Stem, J.
Gao,
GA.
Morgan,
D.
Brees,
T.A.
Schwalb,
M.
Humphreys-Behr,
and J.A.
Smith
107.
Flow
Cytometric
Analysis of the Inflammatory Marker
Hla
Dr
in Dry Eye Syndrome: Results
from
12
Months of Randomized Treatment with Topical Cyclosporin A
.............................761
С
Baudouin,
F.
Brignole,
P J. Pisella, M. De
Saint Jean, and A. Goguel
108.
Pathogenesis of Autoimmune
Lacrimal
Gland Disease in MRL/MpJ Mice
.......................................771
D.A. Jabs, R.A. Prendergast, and J. Whittum-Hudson
109.
ICAM-1
:
Its Role in the Pathophysiology of Immune Activation in the MRL/lpr Mouse
..................777
J.
Gao,
G.A. Morgan,
D.D.
Tieu, T.A.
Schwalb,
M.
Ngo and M.E. Stern
110.
Proinflammatory Cytokine Inhibition of
Lacrimal
Gland Secretion
...................................................783
C. Kublin,
R.
Hodges, and D. Zoukhri
HI. Effect of Anti-Inflammatory Cytokines on the Activation of Lymphocytes by
Lacrimal
Gland
Acinar Cells in an Autologous Mixed Cell Reaction
.............................................................789
M.D. Trousdale, D. Stevenson,
Z. Zhu, H.R.
Kaslow, J.E. Schechter,
D.W.
Warren,
A.M. Azzarolo,
T. Ritter,
and A.K. Mircheff
112.
IL-2 Immunoreactive Protein in
Lacrimal
Acinar Cells
........................................................................795
Y. Zhang, J. Xie, L. Own, J.E. Schechter, and A.K. Mircheff
113.
Immunopamogenesis of Conjunctival Histopathologic Alteration in
Non-Sjögren s
Keratoconjunctivitis Sicca
.............................................................................. ............801
H.Q. Ye, C.C. Chan, and
JA.
Smith
114.
Topical Cyclosporin A
(2 %)
Eyedrops in the Therapy of Atopic Keratoconjunctivitis
and Keratoconjunctivitis Vemalis
...........................................................................................805
I. Tomida, J. Bratining, T,
Schlote, P.E. Heide,
and
M.
Zierhut
Immunity and Inflammation II: Role of Apoptosis,
Antibodies and Mucosal Associated Lymphoid Tissue
115.
Apoptosis: The Eyes Have It
..................................................................................................................815
B.D.
Elzey and T.A. Ferguson
116.
Apoptosis in the Cornea in Response to Epithelial Injury: Significance to Wound Healing
and Dry Eye
.............................................................................................................................821
S.E. Wilson, R. Mohan, J.W. Hong, J.S. Lee, R. Choi, J.J. Liu, and R. Mohan
117.
Mechanism of Apoptosis in Human
Corneal
Epithelial Cells
..............................................................827
F.
Stapleton,
J.M.
Kim,
J.
Kasses,
and M.D.P. Willcox
118.
A Functional Unit For Ocular Surface Immune Defense Formed by the
Lacrimal
Gland,
Conjunctiva and
Lacrimal
Drainage System
...........................................................................835
E. Knop
and
N.
Knop
119.
Role of Tear
Апй-Лсап/йажоеба
IgA in Acanthamoeba
Keratitis
......................................................845
J.Y. Niederkorn, H. Alizadeh, H. Leher,
S. Apte, S.
EI
Agha,
L.
Ling,
M.
Hurt,
К.
Howard,
H.D. Cavanagh, and J.P. McCulley
і
20.
Expression of Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) in the
Conjunctiva
-
A Potential Link between Lympangiogenesis and Leukocyte Trafficking
on the Ocular Surface
...............................................................................................................
85
P. Hamrah, Q. Zhang, and M.R. Dana
121.
Human
Lacrimal
Drainage-Associated Lymphoid Tissue (LDALTJBelongs to the Common
Mucosal Immune System
.........................................................................................................
E. Knop
and
N.
Knop
122.
The Crypt System Of The Human Conjunctiva
...................................................................................
867
N.
Knop
and
E. Knop
123.
Organized Mucosa-Associated Lymphoid Tissue in Human Nasolacrimal Ducts
.............................873
F.P. Paulsen, J.I. Paulsen,
A.B.
Thale, U. Schaudig, and B.N.
Tillmann
Contact Lenses: Impact on the Tear Film
and Ocular Surface
124.
Contact Lenses and Tear Film Interactions
...........................................................................................
M. Willcox, D. Pearce, M. Tan, G. Demirci, and F. Carney
125.
Effects ofCvTransmissibility on
Corneal
Epithelium After Daily and Extended Contact
Uns
Wear in Rabbit and Man
.......................................................................... ■ ........... ..........
P. Ladage, K. Yamamoto, L. Li, D. Ren, W. M.
Petroli,
J.V. Jester, and H.D. Cavanagh
126.
Influence of the Tear Film Composition on Tear Film Structure and Symptomatology of Soft ^
Contact Lens Wearers
..............................................................................................................
M. Guillon,
С
Maissá,
К.
Girard-Claudon, and P. Cooper
127.
Evaluation of the Pre-Lens Tear Film Forming on Three Disposable Contact Lenses
.......................901
J.P. Guillon, J. Morris, and B. Hall
xxi
128.
An Evaluation of
Mucin
Balls Associated with High Dk
Silicone Hydrogel
Contact Lens Wear
.....917
J. P. Craig, T. Sherwin,
C. Grupcheva,
and C.N.J. McGhee
129.
Cells Collected from the
Corneal
Surface in
Sjögren s
Syndrome, Dry Eye, and Normals
...............925
S. Al-OIiky,
С
Begley, G. Lowther, and G. Wilson
130.
The Thickness of the Post-Lens Tear Film Measured by
Interferometry
............................................929
J.J. Nichols and
P.E.
King-Smith
131.
Tear
Lipid
Composition of Hydrogel Contact Lens Wearers
..............................................................935
C.
Maïssa, M.
Guillon,
К.
Girard-Claudon, and P. Cooper
132.
Conjunctival Characteristics of Contact Lens Wearers and Nonwearers and Their Association
with Symptomatology
..............................................................................................................939
M. Guillon, K. Girard-Claudon,
С
Maissá,
and P. Cooper
133.
Dry Eye Symptomatology of Contact Lens Wearers and Nonwearers
................................................945
M. Guillon, P. Cooper,
С
Maïssa,
and
К.
Girard-Claudon
134.
Contact Lens-Induced Papillary Conjunctivitis is Associated with Increased Albumin Deposits
on Extended Wear Hydrogel Lenses
.......................................................................................951
M.E. Tan, G. Demirci, D. Pearce, I. Jalbert, P. Sankaridurg, and M.D.P. Willcox
135.
Surface Protein Profile of Extended-Wear Silicon Hydrogel Lenses
..................................................957
D. Pearce, M. Tan, G. Demirci, and M.D.P. Willcox
136.
The Detection of
Kinin
Activity in Contact Lens Wear
.......................................................................961
A.M. Mann and B.J. Tighe
1
37.
Immunoblotting and Tear Sampling Techniques for the Study of Contact Lens-Induced
Variations in Tear Protein Profiles
..........................................................................................967
H. Peach, A. Mann, and B. Tighe
138.
Interaction between the Contact Lens and the Ocular Surface in Superior Epithelial Arcuate
Lesions (SEALS)
.....................................................................................................................973
N. O Hare, F.
Stapleton, T. Naduvilath,
I.
Jaibert, D.F.
Sweeney, and B.A.
Holden
139.
Clinical Benefits and Physical Properties of Addition of Hydroxypropyl Methylcellulose to a
Multi-Purpose Contact Lens Care Solution
............................................................................981
P.A.
Simmons, W. Kelly, W. Prather, and J. Vehige
Epidemiology and Pathogenesis of Dry Eye Syndromes
(е
-g.
Sjögren s
Syndrome)
140.
Epidemiology of Dry Eye Syndrome
....................................................................................................989
D.A.
Schaumberg, D.A.
Sullivan, and M.R. Dana
141.
Immunogenetics of Autoimmune Exocrinopathy in the NOD Mouse: More Than Meets the
Eye
............................................................................................................................................999
M.G. Humphreys-Beher, J. Brayer,
S. Cha,
H. Nagashima, S.
Diggs, and
A.B.
Peck
142.
Results of a Dry Eye Questionnaire from Optometric Practices in North America
..........................1009
С
Begley, B. Caffery, K. Nichols, G. Lynn Mitchell, R. Chalmers,
and The
DREI
Study Group
143.
The Effect of Hormone Replacement Therapy on the Symptoms and Physiologic Parameters
of Dry Eye
..............................................................................................................................1017
W.D. Mathers, A.M. Dolney, and D. Kraemer
xxii
144.
Impaired
Neurotransmission
in
Lacrimal
and Salivary Glands of
a Murine
Model of
Sjögren s
Syndrome
.................................................................................................................. 1023
D. Zoukhri and
CL. Küblin
145.
Menopause, Hormone Replacement Therapy and Tear Function
......................................................1029
V. Evans, T.J. Millar, J.A. Eden, and M.D.P. Willcox
146.
IDD3 and IDD5
Alíeles
from NOD Mice Mediate
Sjögren s
Syndrome-Like Autoimmunity
........1035
S. Cha,
H. Nagashima,
A.B.
Peck, and M.G. Humphreys-Beher
147.
Dry Eye Associated with Chronic Graft-Versus-Host Disease
..........................................................1041
Y. Ogawa, M. Kuwana, K. Yamazaki, Y. Mashima, S. Okamoto, K. Tsubota, Y. Oguchi,
and Y. Kawakami
148.
Contribution of Neurogen Inflammation to Irritable Eye Syndrome
................................................1047
J. Feher
149.
Ocular Drying Associated with Oral Antihistamines (Loratadine) in Normal Population
-
an
Evaluation of Exaggerated Dose Effect
................................................................................1051
D. Welch, G.W. Ousler III, L.A. Nally, M.B. Abelson, and K.A. Wilcox
150.
An Evaluation of the Time to Natural Compensation During Exposure to a Controlled
Adverse Environment
(CAE)
in Normal and Dry Eye Populations
.....................................1057
G.W. Ousler III, M.B. Abelson, L.A. Nally, D. Welch, and J.S. Casavant
Dry Eye Syndromes: Diagnosis, Clinical Trials and
Pharmaceutical Treatment
151.
Diagnosis and Treatment of Dry Eye: A Clinical Perspective
...........................................................1067
J. D. Nelson
152.
Dry Eye Syndromes: Diagnosis, Clinical Trials, and Pharmaceutical Treatment. Improving
Clinical Trials
.......................................................................................................................1074
M.B. Abelson, G.W. Ousler III, L.A. Nally, and T.B. Emory
153.
Using Osmolarity to Diagnose Dry Eye: A Compartmental Hypothesis and a Review of Our
Assumptions
...........................................................................................................................1087
A.J.
Bron, J.M.
Tiffany,
N.
Yokoi, and S.M.
Gouveia
154.
Reliability of Measurements of Tear Physiology
...............................................................................
A. Tomlinson, L.C. Thai, M.G. Doane, and A. McFadyen
155.
Use of Cevimeline, a Muscarinic Ml and M3 Agonist, in the Treatment of
Sjögren s
Syndrome
................................................................................................................................
R.I. Fox
156.
Drug Development Issues in Pharmacological Treatments for Dry Eye
...........................................1117
G.D. Novack
157.
Alternative Reference Values for Tear Film Break-Up Time in Normal and Dry Eye
Populations
............................................................................................................................. 121
M.B. Abelson, G.W. Ousler III, L.A. Nally, D. Welch, and K. Krenzer
158.
Ocular Sensations and Symptoms Associated with Tear Break-Up
..................................................1127
CG.
Begley, D.
Renner,
G.
Wilson,
S.
Al-Oliky, and T. Simpson
xxiii
159. Evaluation
of the
Akom
Dry Eye Test
(DET)
as a Predictor of Contact Lens Comfort
...................1135
D. Higgins, K.Webb, S. Shapleigh, D. Huebner, T. Carmolli, and B. Hall
160.
Predicting Optical Effects of Tear Film Break-Up on Retinal Image Quality Using
the Shack-Hartmann Aberrometer and Computational Optical Modeling
..........................1141
N.L. Himebaugh, L.N. Thibos,
CG.
Begley, A. Bradley, and G. Wilson
161.
Improvement of Tear Stability Following Warm Compression in Patients with Meibomian
Gland Dysfunction
.................................................................................................................
П49
E. Goto, K. Endo, A. Suzuki, Y.
Fujikura,
and K. Tsubota
162.
An Evaporative Stress Test for Borderline Dry Eye Detection
.........................................................1153
S. Barabino, G.
Melica,
S. Alongi, G.
Calabria, and M. Rolando
163.
Tear Production Measurement, Basal or Reflex Assessment?
...........................................................1159
J. P. Craig, A. Tomlinson,
N.
S. Patterson, V.E.H. Reid, and A.K. McFadyen
164.
Innovative Dry Eye Diagnosis System Using
Microbalance
Technology
........................................1165
K. Endo, E. Goto, A. Suzuki, Y.
Fujikura,
and K. Tsubota
165.
The Repeatability of Diagnostic Tests and Surveys in Dry Eye
........................................................1171
K.K. Nichols and K. Zadnik
166.
Association of Clinical Diagnostic Tests and Dry Eye Surveys: the NEI-VFQ-25 and
theOSDI
.................................................................................................................................1177
K.K. Nichols and J.A. Smith
167.
Economic and Quality of Life Impact of Dry Eye Symptoms in Women with
Sjögren s
Syndrome
................................................................................................................................1183
R.M. Sullivan,
Ш.
Cermak, A.S. Papas, M.R. Dana, and D.A. Sullivan
168.
Patient-Reported Versus Doctor-Diagnosed Dry Eye: the Assessment of Symptoms
.....................1189
G.L. Mitchell, K.K. Nichols, B. Caffery, R. Chalmers,
CG.
Begley,
and The
DREI
Study Group
169.
Keratoconjunctivitis Sicca Versus Dry Mouth and Autoantibodies in Primary and Secondary
Sjögren s
Syndrome
...............................................................................................................1195
K. Kitagawa, T. Nakamura, and S.
Sugai
170.
Tears Spreading Rates: Post-Blink
......................................................................................................1201
H. Owens and J.R Phillips
171.
Near Vision Accommodation in Horizontality with VDT: Why Low Blinking and Dry Eye?
........1205
J. Murube and E. Murube
172.
Analysis of Tear Protein Patterns for the Diagnosis of Dry Eye
.......................................................1213
F.H.
Grus,
P. Sabuncuo, S.
Herber,
and A.J.
Augustin
173.
The Significance of Salivary Gland Ultrasonography in Diagnosis of Dry Eye Syndrome
.............1217
I.
Switka-Wieçlawska,
L. Portacha,
T. Keçik,
and H. Markiewicz
174.
The Effect of Nasal Mucosal Stimulation on Schirmer Tests in
Sjögren s
Syndrome and Dry Eye
Patients
...................................................................................................................................1221
A. Fujisawa, K. Kitagawa, and S.
Sugai
175.
A Simple Method of Detecting the Anti-Inflammatory Action of Topical Dry Eye Treatments
1227
D.L. MacKeen and
Н
-W.
Rom
xxiv
176.
Efficacy of Sodium Hyaluronate Eye Drops of Different Osmolarities in the Symptomatic
Treatment of Dry Eye Patients
..............................................................................................1233
G. Milazzo, V. Papa, P. Aragona, S.
Russo,
P.
Russo,
and
A. Di
Bella
177.
Topical Non-Preserved Diclofenac Therapy for Keratoconjunctivitis Sicca
....................................1237
M. Rolando, S.
Barattino,
S.
Alongi, and G. Calabria
178.
The Effect of Botulinum Toxin A Treatment on Tear Function Parameters and on the Ocular
Surface
....................................................................................................................................124]
J. Horwath-Winter, J.
Berglöff,
I.
Flögel,
E.-M. Haller-Schober, K.
Müllner,
and O. Schmut
179.
Efficacy of Autologous Serum Application in Patients with Severe Dry Eye
..................................1247
E.
Takamura,
К.
Shinozaki,
H.
Hata,
J. Yukari,
and S.
Hori
180.
Ocular Safety of INS365 Ophthalmic Solution, a P2Y2 Agonist, in Patients with Mild to
Moderate Dry Eye Disease
...................................................................................................1251
B.R. Yerxa, M. Mundasad, R.N. Sylvester,
J.C. Gorden,
M.
Cooper, and D.J. Kellerman
181.
Ocular Surface Reconstruction with
Amniotic
Membrane Transplantation in Chemical Burn
.......1259
M.S.
Dos
Santos, D. Fairbanks
,
E.A. Pedro,
M.C. Cunha, D. de Freitas, and J.A.P. Gomes
182.
Surgical Reconstruction of the Tear Meniscus at the Lower Lid Margin for Treatment
ofConjunctivocholasis
...........................................................................................................1263
N.
Yokoi, A. Komuro, J. Sugita, Y. Nakamura, and S. Kinoshita
183.
The Effect of
Punctai
Occlusion on Tear Lactoferrin Concentrations in Aqueous Deficient
Dry Eye Patients
.....................................................................................................................1269
V. Reese and P.R. Youngbar
184.
Silicon
Punctai
Plug Insertion in the Treatment of Severe Dry Eye
..................................................1273
K. Shinozaki, E. Takamura, J. Yukari, and S.
Hori
185.
The Application of Atelocollagen Solution for
Lacrimal
Duct Occlusion
........................................1277
J. Onodera,
A. Saito,
J. George, T. Iwasaki, H.
Ito,
Y. Aso,
T.
Hamáno,
A. Kanai,
T. Miyata and Y. Nagai
186.
Atelocollagen
Punctum
Occlusion
for the Treatment of the Dry Eye
...............................................1283
T.
Hamáno
187.
Fiberscopic Observation of Canaliculus after
Punctai
Plug Extrusion
..............................................1285
K. Shimizu,
N.
Yokoi, and S. Kinoshita
Gene, Stem Cell and Surgical Therapy of the
Ocular Surface
188.
Neural Stem Cells for CNS Repair: The State of the Art and Future Directions
..............................1291
K.I. Park, M. Lachyankar, S. Nissim, and E.Y. Snyder
189.
Particle-Mediated Gene Transfer to Ocular Surface Epithelium
........................................................1297
W.W.-Y.
Kao
190.
In Vivo Gene Transfer into
Corneal
Epithelial Progenitor Cells by Viral Vectors
............................1309
T. Igarashi, K. Miyake,
N.
Suzuki, H. Takahashi, and T. Shimada
191.
Gene Therapy for the Prevention of
Corneal
Haze after Keratectomy Excimer Laser Surgery
........1315
A.
Behrens
and P.J. McDonnell
192.
Ex Vivo Preservation and Expansion of Human
Limbai
Epithelial Stem Cells on
Amniotic
Membrane for Treating
Corneal
Diseases with Total
Limbai
Stem Cell Deficiency
..........1323
S.C.G. Tsenfc D.
Meiler,
D.F.
Anderson,
A. Touhami, R.T.F.
Pires, M.
Grüterich,
Α.
Solomon,
E. Espana,
Η.
Sandoval, S.E.
Ti,
and Eiki Goto
193.
Corneal
Blindness from End-Stage
Sjögren s
Syndrome and Graft-Versus-Host Disease
...............1335
C.H. Dohlman, E.J. Dudenhoefer, B.F. Khan, and J.G. Dohlman
Closing Session
194.
Closing Address: The Academic Perspective
.....................................................................................1341
J.L. Ubels
195.
Industry Perspective
..............................................................................................................................1343
B.R. Yerxa
Addendum
Additional Conference Presentations
............................................................................................................1347
Author Index
.................................................................................................................................................1349
Subject Index
................................................................................................................................................1355
xxvi
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV014542210 |
| callnumber-first | Q - Science |
| callnumber-label | QP188 |
| callnumber-raw | QP188.T4 RE216.D78 |
| callnumber-search | QP188.T4 RE216.D78 |
| callnumber-sort | QP 3188 T4 |
| callnumber-subject | QP - Physiology |
| classification_rvk | YO 7105 |
| ctrlnum | (OCoLC)50035786 (DE-599)BVBBV014542210 |
| dewey-full | 617.7/64 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 617 - Surgery & related medical specialties |
| dewey-raw | 617.7/64 |
| dewey-search | 617.7/64 |
| dewey-sort | 3617.7 264 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02926nam a2200661zcb4500</leader><controlfield tag="001">BV014542210</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20030701 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">020626s2002 xxuad|| |||| 10||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2002072992</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)50035786</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV014542210</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QP188.T4</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RE216.D78</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">617.7/64</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YO 7105</subfield><subfield code="0">(DE-625)153952:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Lacrimal gland, tear film, and dry eye syndromes 3</subfield><subfield code="b">basic science and clinical relevance</subfield><subfield code="c">edited by David A. Sullivan ... [et al.]</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Lacrimal gland, tear film, and dry eye syndromes three</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Kluwer Academic/Plenum Publishers</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXVI, 1385 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Advances in experimental medicine and biology</subfield><subfield code="v">v. 506</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Proceedings of the 3rd International Conference on the Lacrimal Gland, Tear Film, and Dry Eye Syndromes: Basic Science and Clinical Relevance, November 15-18, 2000, Maui, Hawaii"--T.p. verso. - Includes bibliographical references and index.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Appareil lacrymal - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Larmes - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Syndromes de l'il sec - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dry Eye Syndromes</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dry eye syndromes</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lacrimal Apparatus</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lacrimal apparatus</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tears</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tears</subfield><subfield code="x">physiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Physiologie</subfield><subfield code="0">(DE-588)4045981-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Keratokonjunktivitis sicca</subfield><subfield code="0">(DE-588)4270782-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tränenapparat</subfield><subfield code="0">(DE-588)4117240-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tränenflüssigkeit</subfield><subfield code="0">(DE-588)4185825-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tränendrüse</subfield><subfield code="0">(DE-588)4185823-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">2000</subfield><subfield code="z">Maui</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Tränendrüse</subfield><subfield code="0">(DE-588)4185823-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Tränenflüssigkeit</subfield><subfield code="0">(DE-588)4185825-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Keratokonjunktivitis sicca</subfield><subfield code="0">(DE-588)4270782-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Tränenapparat</subfield><subfield code="0">(DE-588)4117240-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Physiologie</subfield><subfield code="0">(DE-588)4045981-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sullivan, David A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">International Conference on the Lacrimal Gland, Tear Film and Dry Eye Syndromes</subfield><subfield code="n">3</subfield><subfield code="d">2000</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)1244280-X</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung TU Muenchen</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009891364&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009891364</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 2000 Maui gnd-content |
| genre_facet | Konferenzschrift 2000 Maui |
| id | DE-604.BV014542210 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T19:03:21Z |
| institution | BVB |
| institution_GND | (DE-588)1244280-X |
| language | English |
| lccn | 2002072992 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009891364 |
| oclc_num | 50035786 |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | XXVI, 1385 S. Ill., graph. Darst. |
| publishDate | 2002 |
| publishDateSearch | 2002 |
| publishDateSort | 2002 |
| publisher | Kluwer Academic/Plenum Publishers |
| record_format | marc |
| series2 | Advances in experimental medicine and biology |
| spelling | Lacrimal gland, tear film, and dry eye syndromes 3 basic science and clinical relevance edited by David A. Sullivan ... [et al.] Lacrimal gland, tear film, and dry eye syndromes three New York Kluwer Academic/Plenum Publishers 2002 XXVI, 1385 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Advances in experimental medicine and biology v. 506 "Proceedings of the 3rd International Conference on the Lacrimal Gland, Tear Film, and Dry Eye Syndromes: Basic Science and Clinical Relevance, November 15-18, 2000, Maui, Hawaii"--T.p. verso. - Includes bibliographical references and index. Appareil lacrymal - Congrès Larmes - Congrès Syndromes de l'il sec - Congrès Dry Eye Syndromes Congresses Dry eye syndromes Congresses Lacrimal Apparatus Congresses Lacrimal apparatus Congresses Tears Congresses Tears physiology Congresses Physiologie (DE-588)4045981-0 gnd rswk-swf Keratokonjunktivitis sicca (DE-588)4270782-1 gnd rswk-swf Tränenapparat (DE-588)4117240-1 gnd rswk-swf Tränenflüssigkeit (DE-588)4185825-6 gnd rswk-swf Tränendrüse (DE-588)4185823-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 2000 Maui gnd-content Tränendrüse (DE-588)4185823-2 s DE-604 Tränenflüssigkeit (DE-588)4185825-6 s Keratokonjunktivitis sicca (DE-588)4270782-1 s Tränenapparat (DE-588)4117240-1 s Physiologie (DE-588)4045981-0 s Sullivan, David A. Sonstige oth International Conference on the Lacrimal Gland, Tear Film and Dry Eye Syndromes 3 2000 Sonstige (DE-588)1244280-X oth Digitalisierung TU Muenchen application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009891364&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Lacrimal gland, tear film, and dry eye syndromes 3 basic science and clinical relevance Appareil lacrymal - Congrès Larmes - Congrès Syndromes de l'il sec - Congrès Dry Eye Syndromes Congresses Dry eye syndromes Congresses Lacrimal Apparatus Congresses Lacrimal apparatus Congresses Tears Congresses Tears physiology Congresses Physiologie (DE-588)4045981-0 gnd Keratokonjunktivitis sicca (DE-588)4270782-1 gnd Tränenapparat (DE-588)4117240-1 gnd Tränenflüssigkeit (DE-588)4185825-6 gnd Tränendrüse (DE-588)4185823-2 gnd |
| subject_GND | (DE-588)4045981-0 (DE-588)4270782-1 (DE-588)4117240-1 (DE-588)4185825-6 (DE-588)4185823-2 (DE-588)1071861417 |
| title | Lacrimal gland, tear film, and dry eye syndromes 3 basic science and clinical relevance |
| title_alt | Lacrimal gland, tear film, and dry eye syndromes three |
| title_auth | Lacrimal gland, tear film, and dry eye syndromes 3 basic science and clinical relevance |
| title_exact_search | Lacrimal gland, tear film, and dry eye syndromes 3 basic science and clinical relevance |
| title_full | Lacrimal gland, tear film, and dry eye syndromes 3 basic science and clinical relevance edited by David A. Sullivan ... [et al.] |
| title_fullStr | Lacrimal gland, tear film, and dry eye syndromes 3 basic science and clinical relevance edited by David A. Sullivan ... [et al.] |
| title_full_unstemmed | Lacrimal gland, tear film, and dry eye syndromes 3 basic science and clinical relevance edited by David A. Sullivan ... [et al.] |
| title_short | Lacrimal gland, tear film, and dry eye syndromes 3 |
| title_sort | lacrimal gland tear film and dry eye syndromes 3 basic science and clinical relevance |
| title_sub | basic science and clinical relevance |
| topic | Appareil lacrymal - Congrès Larmes - Congrès Syndromes de l'il sec - Congrès Dry Eye Syndromes Congresses Dry eye syndromes Congresses Lacrimal Apparatus Congresses Lacrimal apparatus Congresses Tears Congresses Tears physiology Congresses Physiologie (DE-588)4045981-0 gnd Keratokonjunktivitis sicca (DE-588)4270782-1 gnd Tränenapparat (DE-588)4117240-1 gnd Tränenflüssigkeit (DE-588)4185825-6 gnd Tränendrüse (DE-588)4185823-2 gnd |
| topic_facet | Appareil lacrymal - Congrès Larmes - Congrès Syndromes de l'il sec - Congrès Dry Eye Syndromes Congresses Dry eye syndromes Congresses Lacrimal Apparatus Congresses Lacrimal apparatus Congresses Tears Congresses Tears physiology Congresses Physiologie Keratokonjunktivitis sicca Tränenapparat Tränenflüssigkeit Tränendrüse Konferenzschrift 2000 Maui |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009891364&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT sullivandavida lacrimalglandtearfilmanddryeyesyndromes3basicscienceandclinicalrelevance AT internationalconferenceonthelacrimalglandtearfilmanddryeyesyndromes lacrimalglandtearfilmanddryeyesyndromes3basicscienceandclinicalrelevance AT sullivandavida lacrimalglandtearfilmanddryeyesyndromesthree AT internationalconferenceonthelacrimalglandtearfilmanddryeyesyndromes lacrimalglandtearfilmanddryeyesyndromesthree |